Empress Therapeutics CEO and Flagship Operating Partner Jason Park shares how Empress is converging the power of genetics and a digital data-driven AI approach to revolutionize small molecule drug discovery. More from Flagship @ JPM2024 here.
Related Companies
- Empress Therapeutics Founded: 2020
